GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Taigen Biopharmaceuticals Holdings 4157.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

8.13

+4.10%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 259.5m

FY2016FY2025

Net income

TWD 45.2m

FY2016FY2025

Free cash flow

TWD 16.4m

FY2016FY2025

Shareholders' equity

TWD 1.07bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 259.5mTWD 150.7mTWD 123.1mTWD 36.2mTWD 1.29bnTWD 23.4mTWD 20.3mTWD 29.6mTWD 553.2mTWD 146.0m
Research and developmentTWD 96.9mTWD 166.1mTWD 187.5mTWD 237.5mTWD 283.3mTWD 249.4mTWD 223.6mTWD 197.5mTWD 190.7mTWD 263.9m
Operating incomeTWD 69.4m−TWD 122.1m−TWD 174.7m−TWD 217.2mTWD 876.2m−TWD 403.8m−TWD 287.0m−TWD 258.4mTWD 260.4m−TWD 237.7m
Net incomeTWD 45.2m−TWD 38.6mTWD 136.7m−TWD 237.2mTWD 775.6m−TWD 404.8m−TWD 295.7m−TWD 343.2mTWD 746.4m−TWD 250.0m
Diluted earnings per share0.06-0.050.19-0.331.04-0.57-0.40-0.471.02-0.34

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 1.17bnTWD 1.17bnTWD 1.23bnTWD 1.05bnTWD 1.39bnTWD 556.4mTWD 946.1mTWD 1.19bnTWD 1.52bnTWD 823.4m
Cash and short-term investments——TWD 1.04bnTWD 899.5mTWD 924.4mTWD 330.8mTWD 652.6mTWD 782.4mTWD 1.05bnTWD 696.7m
Total liabilitiesTWD 92.4mTWD 92.0mTWD 110.9mTWD 77.0mTWD 139.1mTWD 114.3mTWD 130.9mTWD 94.4mTWD 97.7mTWD 147.8m
Debt——TWD 74.7mTWD 38.5mTWD 53.5mTWD 17.1mTWD 66.2m———
Shareholders' equityTWD 1.07bnTWD 1.08bnTWD 1.12bnTWD 970.0mTWD 1.25bnTWD 442.2mTWD 815.2mTWD 1.09bnTWD 1.42bnTWD 675.6m
Shares outstanding713m713m718m717m745m710m734m733m729m725m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 20.9m−TWD 173.1mTWD 20.7m−TWD 21.3mTWD 629.1m−TWD 242.1m−TWD 342.5m−TWD 254.9m−TWD 266.9m−TWD 152.8m
Capital spending−TWD 4.5m−TWD 2.7m−TWD 7.4m−TWD 7.5m−TWD 11.8m−TWD 8.4m−TWD 5.1m−TWD 23.0m−TWD 18.1m−TWD 10.7m
Free cash flowTWD 16.4m−TWD 175.8mTWD 13.3m−TWD 28.7mTWD 617.2m−TWD 250.5m−TWD 347.6m−TWD 277.9m−TWD 285.0m−TWD 163.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 8.2mTWD 10.3mTWD 231.2mTWD 6.7mTWD 10.7mTWD 10.9mTWD 10.5mTWD 8.6m
Operating income−TWD 29.1m−TWD 35.2mTWD 187.7m−TWD 40.7m−TWD 36.3m−TWD 41.3m−TWD 53.9m−TWD 59.1m
Net income−TWD 21.3m−TWD 14.3mTWD 204.7m−TWD 14.0m−TWD 122.9m−TWD 22.7m−TWD 24.7m−TWD 72.0m
Diluted earnings per share-0.03-0.020.29-0.02-0.17-0.03-0.03-0.10
Cash from operations−TWD 41.0mTWD 111.0mTWD 46.0m−TWD 62.0m−TWD 30.0mTWD 67.0mTWD 26.0mTWD 21.0m
Capital spending—−TWD 18.0m−TWD 2.0m———−TWD 1.0m—
Free cash flow—TWD 93.0mTWD 44.0m———TWD 25.0m—
Total assetsTWD 1.06bnTWD 1.11bnTWD 1.17bnTWD 1.01bnTWD 1.09bnTWD 1.17bnTWD 1.17bnTWD 1.22bn
Shareholders' equityTWD 1.02bnTWD 1.05bnTWD 1.07bnTWD 892.7mTWD 972.5mTWD 1.05bnTWD 1.08bnTWD 1.11bn

Financial ratios

Data as of 7 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating margin22.8%-20.9%-141.9%-599.4%67.7%-1723.9%—
Net margin17.4%-25.6%111.0%-654.6%59.9%-1728.4%—
Return on equity4.2%-3.6%12.2%-24.4%61.9%-91.6%—
Return on assets3.9%-3.3%11.1%-22.7%55.7%-72.8%—
Free cash flow yield—-2.8%0.5%-0.2%10.2%-3.9%-5.4%
Revenue growth72.2%22.3%239.9%-97.2%5426.9%15.3%—
Earnings growth-217.1%-128.2%-157.7%-130.6%-291.6%36.9%—
Current ratio13.48x23.57x23.19x18.50x13.71x4.13x—
Debt to equity——0.01x0.02x0.01x0.04x0.06x
Equity ratio92.1%92.2%91.0%92.6%90.0%79.5%—
Interest coverage35.50x-22.09x-153.65x-254.27x3591.15x-671.85x—
R&D as a share of sales37.3%110.2%152.3%655.6%21.9%1065.0%—
Buybacks as a share of market value—0.6%-0.1%3.8%-4.9%3.2%-0.2%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue92.8%61.8%12.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-12.9%-78.1%1.5%-34.1%
Net margin1.6%-16.5%14.7%-10.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings211.6-211.779.8-48.514.8-40.1-45.7-36.321.2-78.9
Price to sales36.854.288.6317.68.9——420.628.6135.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.